Serum (1→3)-β-D-Glucan Measurement in Coccidioidomycosis

被引：41
|
作者：
Thompson, George R., III [1 ,2 ]
Bays, Derek J. [1 ]
Johnson, Suzanne M. [1 ]
Cohen, Stuart H. [2 ]
Pappagianis, Demosthenes [1 ]
Finkelman, Malcolm A. [3 ]
机构：
[1] Univ Calif Davis, Dept Med Microbiol & Immunol, Coccidioidomycosis Serol Lab, Davis, CA 95616 USA
[2] Univ Calif Davis, Med Ctr, Dept Internal Med, Div Infect Dis, Sacramento, CA 95817 USA
[3] Associates Cape Cod Inc, E Falmouth, MA USA
来源：
JOURNAL OF CLINICAL MICROBIOLOGY | 2012年 / 50卷 / 09期
关键词：
INVASIVE FUNGAL-INFECTIONS; SURVEILLANCE NETWORK TRANSNET; BETA-D-GLUCAN; TRANSPLANT RECIPIENTS; DIAGNOSIS; POSADASII; LEUKEMIA; MYCOSIS;
D O I：
10.1128/JCM.00631-12
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The serum (1 -> 3)-beta-D-glucan assay has emerged as an important diagnostic test for invasive fungal disease. The utility of this assay in coccidioidomycosis has not been previously studied. Using a cutoff value of >= 80 pg/ml, we found the sensitivity (43.9%), specificity (91.1%), positive predictive value (81.8%), and negative predictive value (64.1%) to be similar to those of the assay in diagnosing other invasive mycoses.
引用
收藏
页码：3060 / 3062
页数：3
相关论文
共 50 条
  • [1] Interference of (1→3)-β-D-glucan Administration in the Measurement of Plasma (1→3)-β-D-glucan
    Ishizuka, Y
    Tsukada, H
    Gejyo, F
    [J]. INTERNAL MEDICINE, 2004, 43 (02) : 97 - 101
  • [2] The Utility of (1→3)-β-D-Glucan Testing in the Diagnosis of Coccidioidomycosis in Hospitalized Immunocompromised Patients
    Al-Obaidi, Mohanad M.
    Ayazi, Parham
    Shi, Aishan
    Campanella, Matthew
    Connick, Elizabeth
    Zangeneh, Tirdad T.
    [J]. JOURNAL OF FUNGI, 2022, 8 (08)
  • [3] Serum (1,3)-β-D-Glucan for Screening of Neonatal Fungemia
    Kamirul Islam
    Nazima Khatun
    Ujjal Mondal
    Kuntalkanti Das
    Kaustav Nayek
    [J]. Indian Pediatrics, 2022, 59 : 499 - 500
  • [4] Serum (1,3)-β-D-Glucan for Screening of Neonatal Fungemia
    Islam, Kamirul
    Khatun, Nazima
    Mondal, Ujjal
    Das, Kuntalkanti
    Nayek, Kaustav
    [J]. INDIAN PEDIATRICS, 2022, 59 (06) : 499 - 500
  • [5] Serum (1-3)-β-D-Glucan measurement is a reliable indicator for Pneumocystis jirovecii (carinii) pneumonia
    Koch, M.
    Serr, A.
    Danner, T.
    Held, J.
    [J]. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2009, 299 : 43 - 43
  • [6] Measurement of (1→3)-β-D-glucan in an experimental model of systemic candidiasis
    Kawagoe, T
    Nakao, A
    Kanbe, T
    Tamura, H
    Tanaka, S
    Takagi, H
    [J]. EUROPEAN SURGICAL RESEARCH, 1998, 30 (04) : 290 - 296
  • [7] Early serum (1→3)-β-D-glucan levels in patients with burn injury
    Shupp, Jeffrey W.
    Petraitiene, Ruta
    Jaskille, Amin D.
    Pavlovich, Anna R.
    Matt, Sarah E.
    Nguyen, Do T.
    Kath, Melissa A.
    Jeng, James C.
    Jordan, Marion H.
    Finkelman, Malcolm
    Walsh, Thomas J.
    Shoham, Shmuel
    [J]. MYCOSES, 2012, 55 (03) : 224 - 227
  • [8] Overview of (1→3)-β-D-glucan immunobiology
    Williams, DL
    [J]. MEDIATORS OF INFLAMMATION, 1997, 6 (04) : 247 - 250
  • [9] Serum (1→3)-β-D-Glucan Assay for the Diagnosis of Pneumocystis jiroveci Pneumonia
    del Palacio, Amalia
    Soledad Cuetara, Maria
    Llenas-Garcia, Jara
    Elena Alvarez, Maria
    Chaves, Fernando
    Pulido, Federico
    Catalan, Mercedes
    Ponton, Jose
    [J]. CLINICAL AND VACCINE IMMUNOLOGY, 2010, 17 (01) : 202 - 203
  • [10] (1→3) β-D-Glucan as a Prognostic Marker
    Chow, Harry
    Hurley, James C.
    [J]. CLINICAL INFECTIOUS DISEASES, 2013, 56 (03) : 466 - 466
12345